Michael Doulberis MD, DVM, PhD, FACP
Michael Doulberis MD, DVM, PhD, FACP
University Hospital Inselspital of Bern, Bern, Switzerland
Verified email at insel.ch
TitleCited byYear
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
M Doulberis, G Kotronis, D Gialamprinou, J Kountouras, P Katsinelos
Metabolism 71, 182-197, 2017
Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice
T Poutahidis, K Cappelle, T Levkovich, CW Lee, M Doulberis, Z Ge, ...
PloS one 8 (8), e73933, 2013
Mycotic encephalitis and nephritis in a dog due to infection with Cladosporium cladosporioides
T Poutahidis, K Angelopoulou, E Karamanavi, ZS Polizopoulou, ...
Journal of comparative pathology 140 (1), 59-63, 2009
Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis
J Kountouras, SA Polyzos, M Doulberis, C Zeglinas, F Artemaki, ...
Metabolism 87, 18-24, 2018
Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes‐like approach?
SA Polyzos, J Kountouras, S Anastasiadis, M Doulberis, P Katsinelos
Hepatology 68 (1), 389-389, 2018
Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
M Doulberis, G Kotronis, R Thomann, SA Polyzos, M Boziki, ...
Helicobacter 23 (1), e12454, 2018
Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view
SA Polyzos, C Zeglinas, F Artemaki, M Doulberis, E Kazakos, ...
Annals of gastroenterology 31 (1), 8, 2018
Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer
M Doulberis, K Angelopoulou, E Kaldrymidou, A Tsingotjidou, Z Abas, ...
Carcinogenesis 36 (2), 280-290, 2014
Update on ischemic colitis: from etiopathology to treatment including patients of intensive care unit
M Doulberis, P Panagopoulos, S Scherz, E Dellaporta, G Kouklakis
Scandinavian journal of gastroenterology 51 (8), 893-902, 2016
The emerging role of Helicobacter pylori-induced metabolic gastrointestinal dysmotility and neurodegeneration
J Kountouras, M Boziki, SA Polyzos, P Katsinelos, E Gavalas, C Zeglinas, ...
Current molecular medicine 17 (6), 389-404, 2017
Primary gastric choriocarcinoma in a dog
T Poutahidis, M Doulberis, E Karamanavi, K Angelopoulou, CK Koutinas, ...
Journal of comparative pathology 139 (2-3), 146-150, 2008
Is there an association between migraine and gastrointestinal disorders?
M Doulberis, C Saleh, S Beyenburg
Journal of Clinical Neurology 13 (3), 215-226, 2017
A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration
M Boziki, SA Polyzos, G Deretzi, E Kazakos, P Katsinelos, M Doulberis, ...
Neurochemistry international 113, 137-151, 2018
Establishment of an animal model for Waldenström's macroglobulinemia
AS Tsingotjidou, CE Emmanouilides, E Siotou, T Poutahidis, A Xagorari, ...
Experimental hematology 37 (4), 469-476, 2009
Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology
J Kountouras, SA Polyzos, P Katsinelos, S Anastasiadis, D Tzivras, ...
Digestive diseases and sciences 63 (4), 1087-1088, 2018
Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease
SA Polyzos, J Kountouras, M Mavrouli, P Katsinelos, M Doulberis, ...
Experimental and clinical endocrinology & diabetes, 2019
Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease-Barrett's esophagus-esophageal adenocarcinoma sequence.
M Doulberis, J Kountouras, SA Polyzos, D Tzivras, E Vardaka, ...
Helicobacter 23 (6), e12534, 2018
Helicobacter pylori Infection and Gastroesophageal Reflux Disease–Barrett’s Esophagus–Esophageal Adenocarcinoma Sequence
J Kountouras, M Doulberis, SA Polyzos, C Zeglinas, E Vardaka, ...
The American journal of gastroenterology 113 (11), 1723, 2018
A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection
J Kountouras, M Doulberis, A Papaefthymiou, SA Polyzos, E Vardaka, ...
Annals of the New York Academy of Sciences, 2019
Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine
J Kountouras, M Doulberis, A Papaefthymiou, SA Polyzos
Annals of gastroenterology, 318-318, 2019
The system can't perform the operation now. Try again later.
Articles 1–20